Hylomorph Medical raises €4.7M Series B round
5 September 2023· Zurich, Switzerland· health, medical_devices, biomaterials, biotech, b2b, deep_hardware
The investment will help the Zurich-based ETH spin-off Hylomorph expand its product portfolio, as well as achieve regulatory approvals and market launch for its first indication in cardiology.
Investors
LeadEFI Lake Geneva Ventures
Also participating
Zürcher KantonalbankVerve VenturesStart Angels Network SwitzerlandInterconsultClub degli InvestitoriExcellis Holding
About Hylomorph Medical
Stage
Series B
Headquarters
Zurich, Switzerland
Founded
2014
Team Size
6–20
Sectors
healthmedical_devicesbiomaterialsbiotechb2bdeep_hardware